Related Articles
Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma
Molecular regulation of S100P in human lung adenocarcinomas
S100P is associated with proliferation and migration in nasopharyngeal carcinoma
S100P, a potential novel prognostic marker in colorectal cancer
S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct